Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the first patient ...

Abstract: This study systematically investigates the roles of messenger RNAs (mRNAs) and microRNAs (miRNAs) in Renal Cell Carcinoma (RCC ... are identified, and survival prognosis-related biomarkers ...

AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...

Background: Current studies on the establishment of prognostic model for renal cell carcinoma (RCC) with liver metastases (LM) were scarce. This study aimed to develop nomograms to predict the ...

The three main methods used to treat cancer are surgical excision, chemotherapy, and radiation therapy. Immunotherapy has had a major impact on the prognosis for treating cancers like renal cell ...

This knowledge offers opportunities to improve cancer therapies and other treatments ... but the process can differ from cell to cell. This makes it important to study DNA repair in individual ...

[Photo/Xinhua] China's five-year cancer survival rate has steadily improved. Still, challenges remain as the country strives to address regional disparities in access to quality cancer prevention ...

The survival rate among those with lung cancer has improved by more than a quarter in the last five years, according to a new report. Four years ago, the United States Preventive Services Task ...

small cell carcinoma and combined small cell carcinoma. Prognosis and treatment will look different depending on the specific type of lung cancer. Understanding the characteristics of each type of ...